三阴性乳腺癌的免疫疗法:对微环境,治疗和耐药性的分子洞察力

Xupeng Bai1,2, Jie Ni1,2, Julia Beretov1,2,3

  • 1St George and Sutherland Clinical School, Faculty of Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.

概括

三阴性乳腺癌 (TNBC) 显示免疫疗法具有前景,但许多患者反应不佳. 本综述探讨了TNBC的免疫微环境和对免疫检查点抑制剂 (ICI) 的耐药性,以改善治疗结果.

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K